compounded semaglutide lawsuit update Inside the Legal Battle Between Novo Nordisk and Hims & Hers Compound versions of GLP-1 drugs

Thats where GLP-1, GIP and glucagon are sending most of their signals to reduce hunger and increase energy expenditure

[DOI] [PubMed] [Google Scholar] 36.Drucker DJ & Holst JJ The expanding incretin universe: from basic biology to clinical translation

2025;135(9):e188314

Originally studied for metabolic and glycemic control, semaglutide has since demonstrated significant efficacy in promoting sustained weight reduction by targeting the physiological drivers of appetite, caloric intake, and metabolic efficiency

It is currently being studied in Phase 2 and Phase 3 clinical trials, and any use outside a formal trial setting is considered unlicensed and is not endorsed by NICE or NHS guidance

What Side Effects Should I Be Aware Of Gastrointestinal symptoms are among the most commonly reported effects of GLP 1 receptor agonists, especially during dose escalation